Marinus Pharmaceuticals, Inc. (MRNS)

Last Three Months

18-Feb-24 -- 17-May-24

Time Period:

Three Months
|
Year

($38.71K) Net Amount

Buy:	0	--
Sell:	($38.71K)	$9.56 - $9.57

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

23

0

1

+1

0

+2

0

+3

Two Year Chart

18-May-22 -- 17-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Mar-24 11:55 AM View:	27-Mar-24 Option Exercise $214.00K	Braunstein Scott Chairman and CEO Director		Marinus Pharmaceuticals, Inc. - MRNS	22% 223.51K to 273.51K	0	0	--	--	Show Txns Hide Txns

22-Feb-24 4:05 PM View:	20-Feb-24 Market Sale (Planned) ($20.58K)	Shafer Christina Chief Commercial Officer		Marinus Pharmaceuticals, Inc. - MRNS	(3%) 62.46K to 60.31K	0	($20.58K) (3%)	--	$9.56	Show Txns Hide Txns

22-Feb-24 4:05 PM View:	20-Feb-24 Market Sale (Planned) ($18.13K)	Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.		Marinus Pharmaceuticals, Inc. - MRNS	(3%) 54.86K to 52.97K	0	($18.13K) (3%)	--	$9.57	Show Txns Hide Txns